Flora Peyvandi: Key Guidance from ISTH on Pediatric Antithrombotic Therapies
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Neil A. Goldenberg et al, adding:
“Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group – Journal of Thrombosis and Haemostasis.”
Title: Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group
Authors: Neil A. Goldenberg, Scott D. Berkowitz, Marisol Betensky, Susanne Holzhauer, Vera Ignjatovic, Amy Kiskaddon, Daniel Schaufelberger, Paul Monagle, Christoph Male
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 17, 2026, 13:27Abdalraheim Mustafa: Comparative Analysis of Thrombophilia and Thrombocytosis in Clinical Practice
-
Apr 17, 2026, 13:25Emphasizing The Importance Of Early Diagnosis For Improving Hemophilia Care In Armenia – Yeolyan Hematology and Oncology Center
-
Apr 17, 2026, 12:44Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
-
Apr 17, 2026, 12:15Zain Khalpey: The Hidden Impact of Sex Hormones on Thrombosis and Heart Health
-
Apr 17, 2026, 09:54Andrew Aswani: How NETs Contribute to Disease and Why They Matter
-
Apr 17, 2026, 09:49Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
-
Apr 17, 2026, 09:25The Challanges of Cancer-Associated Thrombosis – ISTH
-
Apr 17, 2026, 08:32Leslie Johns: Our First Low Titer O Whole Blood Products
-
Apr 17, 2026, 08:24Dominique P. Germain: The Critical Role of Cardiac Involvement in Fabry Disease